AbbVie Can't Trim Report In Testosterone Replacement MDL
An Illinois federal judge overseeing multidistrict litigation over heart health risks and injuries allegedly caused by testosterone replacement therapy drugs refused Tuesday to trim an expert report that supports claims against...To view the full article, register now.
Already a subscriber? Click here to view full article